Joe Stephenson

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

Caroline J. Breitbach, James M. Burke, Derek J. Jonker et al. · Nature · 2011 · 550 citations

Pharmacy, Oncology, Pharmaceutics +12

First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors

Kyriakos P. Papadopoulos, Larry Gluck, Lainie P. Martin et al. · Clinical Cancer Research · 2017 · 208 citations

Medicine, Oncology, Pharmacology +17

A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer

Hedy L. Kindler, Donald Richards, Lawrence Garbo et al. · Annals of Oncology · 2012 · 191 citations · Full text

Medicine, Oncology, Pharmacology +14

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Mitesh J. Borad, Shantan Reddy, Nathan Bahary et al. · Journal of Clinical Oncology · 2014 · 191 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma

Tae-Ho Hwang, Anne Moon, James M. Burke et al. · Molecular Therapy · 2011 · 159 citations · Full text

Medicine, Immunology, Oncology +16